InvestorsHub Logo
icon url

misiu143

05/25/21 2:45 PM

#167729 RE: stockorus #167726

This is usually not needed.

What we need is fair distribution of patients by age .
In CD12 everything was not proper , somehow..

Study was....... 2:1 , drug : placebo
age over 65 ....3:1 , drug : placebo.

This what was a big problem..
And I cant even explain how this could happen..



icon url

Hookmeistr

05/25/21 8:16 PM

#167819 RE: stockorus #167726

Sorry, I hadn't yet read your post on the upper end age limit restriction potential need.